Gate2Brain
  • Home
  • Company
    • Mission & vision
    • Awards & Recognitions
    • Seals & Product Designations
    • Supported by
  • About us
    • Founders
    • Team
    • Advisory board
    • Values
    • Our Story
  • Technology
    • Scientific Publications
  • Pipeline-Proof of Concept
  • Investors
  • ESG
  • News & Media
  • Contact
  • Menu Menu

Gate2Brain wants to deliver drugs to the brain to combat intact barrier brain tumors, such as DIPG

Media & Press, News
Paidhos

 

Fuente: Paidhos

July 13, 2022/by noticias
Tags: Biotech, Gate2Brain, SJD
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2022/07/Captura-de-Pantalla-2022-07-13-a-las-13.43.15-1.png 402 598 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2022-07-13 12:45:152025-02-19 09:40:52Gate2Brain wants to deliver drugs to the brain to combat intact barrier brain tumors, such as DIPG
You might also like
Grit International Female Accelerator!Grit International Female AcceleratorG2B joined the Grit International Female Accelerator
GATE2BRAIN winner of the Barcelona Activa Pre-acceleration competitionBarcelona ActivaGate2Brain winner of the Barcelona Activa Pre-Acceleration Competition
CaixaImpulsGate2Brain as alumni at Caixa Impulse Validate
Gate2Brain and Intact Barrier Brain Tumors: A Ray of Hope in the Fight against DIPG
Plug & Play Biotech Pitch
Meritxell Teixidó això de semblar una superwomen em patina moltDiari AraI couldn’t care less about looking like a “superwoman”
‘Tractor’ proteins that carry drugs to the brain as therapy for incurable pediatric cancer
Gate2Brain will be attending in Basel, Switzerland, the Investment Readiness Series, a @Biocat initiative co-organized by the Delegation of the Government of Catalonia in Switzerland, The aim of the meeting is to put the best projects - from companies and/or research organizations - in contact with investors, business angels, venture capitalists and leading Swiss companies.Gate2Brain will be attending The Investment Readiness Series

CATEGORIES

  • Advisory Board
  • Events
  • Funding & Breakthroughs
  • Interviews
  • Media & Press
  • Media Coverage
  • News
  • Podcasts
  • Press releases
  • Research & Publications
  • Sin categoría
  • Video Content

Events

  • Gate2Brain to Participate in the Barcelona Deep Tech Summit 2025November 3, 2025 - 10:23
  • Gate2Brain at BioJapan 2025 — Enabling Innovative Brain Delivery SolutionsOctober 15, 2025 - 12:56
  • Gate2Brain turns 5!July 9, 2025 - 18:07
  • Bioengineering the Future of Drug Delivery workshop – PortoApril 8, 2025 - 10:03
  • Gate2Brain at the 2nd Peptide-Based Therapeutics Summit | BostonMarch 26, 2025 - 15:34

SOCIAL

  • linkedin
  • youtube
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
Gate2Brain at “Digitalizing and reindustrializing Spain with the recovery...Thank you for inviting Gate2Brain last Friday to the conference "DIGITALIZING AND REINDUSTRIALIZING SPAIN WITH THE RECOVERY PLAN". The purpose of this conference, focused on the digital axis of the Recovery Plan, was to give visibility to some of the digitization projects that have already received funding from the Plan in different areas and that are already contributing to this transformation, as well as to present the evolution of the Digital Spain agenda.Asuntos Económicos y transformación digitalNadia Calviño, First Vice President of the Government and Minister of Economic Affairs visits Gate2BrainSJDNadia Calviño, First Vice President of the Government visits Gate2Brain
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}